Evaluation of the Value of Fasting Plasma Glucose in the First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China
Open accessThe DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the value of fasting plasma glucose (FPG) value in the first prenatal visit to diagnose gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS: Medical records of 17,186 pregnant women attending prenatal clinics in 13 hospitals in China, including the Peking University First Hospital (PUFH), were examined. Patients with pre-GDM were excluded; data for FPG at the first prenatal visit and one-step GDM screening with 75-g oral glucose tolerance test (OGTT) performed between 24 and 28 weeks of gestation were collected and analyzed. RESULTS: The median ± SD FPG value was 4.58 ± 0.437. FPG decreased with increasing gestational age. FPG level at the first prenatal visit was strongly correlated with GDM diagnosed at 24–28 gestational weeks (χ2 = 959.3, P < 0.001). The incidences of GDM were 37.0, 52.7, and 66.2%, respectively, for women with FPG at the first prenatal visit between 5.10 and 5.59, 5.60 and 6.09, and 6.10–6.99 mmol/L. The data of PUFH were not statistically different from other hospitals. CONCLUSIONS: Pregnant women (6.10 ≤ FPG < 7.00 mmol/L) should be considered and treated as GDM to improve outcomes; for women with FPG between 5.10 and 6.09 mmol/L, nutrition and exercise advice should be provided. An OGTT should be performed at 24–28 weeks to confirm or rule out GDM. Based on our data, we cannot support an FPG value ≥5.10 mmol/L at the first prenatal visit as the criterion for diagnosis of GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Universal screening is recommended, as selective screening (only in women with risk factors) would miss a significant number of women with GDM and universal screening has been shown to be cost-effective compared with selective screening.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, in a large Chinese cohort, many women with FPG in the first trimester above the IADPSG threshold for GDM did not have GDM when tested later in gestation (279).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [279]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early abnormal glucose metabolism, defi ned as a fasting glucose threshold of 110 mg/dL (6.1 mmol/L) or an A1C of 5.9% (41 mmol/mol), may identify individuals who are at higher risk of adverse pregnancy and neonatal outcomes (preeclampsia, macrosomia, shoulder dystocia, and perinatal death), are more likely to need insulin treatment, and are at high risk of a later GDM diagnosis (189 -194).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [189]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early abnormal glucose metabolism, defined as a fasting glucose threshold of 110 mg/dL (6.1 mmol/L) or an A1C of 5.9% (41 mmol/mol), may identify individuals who are at higher risk of adverse pregnancy and neonatal outcomes (preeclampsia, macrosomia, shoulder dystocia, and perinatal death), are at high risk of a later GDM diagnosis, and are more likely to need insulin treatment (174-176).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [174]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Universal screening is recommended, as selective screening (only in women with risk factors) would miss a significant number of women with GDM and universal screening has been shown to be cost-effective compared with selective screening.9,50–55”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [50]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Committee Opinion No. 504: Screening and Diagnosis of Gestational Diabetes Mellitus
(2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182310cc3 · Cited by 153
RetractedHyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253
Prevalence of Diabetes among Men and Women in China
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908292 · Cited by 3,031
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
First-Trimester Fasting Hyperglycemia and Adverse Pregnancy Outcomes
Riskin-Mashiah, S., Younes, G., Damti, A., & Auslender, R. (2009) · Diabetes Care · doi:10.2337/dc09-0688 · Cited by 277 · cited 2×
“A study in 2009 reported that higher first-trimester fasting glucose increases the risk for some complications and implied that high-risk women would not get appropriate attention if the diagnosis was not made during the first prenatal visit (14).”
BackgroundMills, J. L., Jovanovic, L., Knopp, R., Aarons, J., Conley, M., Park, E., Lee, Y. J., Holmes, L., Simpson, J. L., & Metzger, B. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90290-6 · Cited by 199 · cited 2×
“(15) in 1998 showed that the fasting blood glucose levels decrease with advancing pregnancy and a plateau occurs around 10–20 weeks.”
BackgroundBody Weight and Subsequent Diabetes Mellitus
O'Sullivan, J. B. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03330080031024 · Cited by 196
Cited by
Items 101–200 of 346
Diagnosis of Gestational Diabetes Mellitus in China: Perspective, Progress and Prospects
Juan, J., Yang, H.-X., Su, R., & Kapur, A. (2019) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000008 · Cited by 35
Self-citationExposure of Pregnant Mice to Triclosan Causes Insulin Resistance via Thyroxine Reduction
Xu, H., Cao, X., Wang, X., Sun, P. G., & Chen, L. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx166 · Cited by 32
Xu, C., Ma, H.-H., & Wang, Y. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0346-4 · Cited by 32
Self-citationMaternal Obesity Affects the Glucose-Insulin Axis During the First Trimester of Human Pregnancy
Bandres‐Meriz, J., Dieberger, A. M., Hoch, D., Pöchlauer, C., Bachbauer, M., Glasner, A., Niedrist, T., van Poppel, M. N. M., & Desoyé, G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.566673 · Cited by 32
“However, despite their importance, metabolic changes in obese mothers early in pregnancy have been poorly described, either in small cohorts, at only a short time period within the first trimester or not fully addressing the glucose-insulin axis (9, 10).”
BackgroundResultPlows, J. F., Budin, F., Andersson, R., Mills, V., Macé, K., Davidge, S. T., Vickers, M. H., Baker, P. N., Silva‐Zolezzi, I., & Stanley, J. L. (2017) · Nutrients · doi:10.3390/nu9020141 · Cited by 33
Angiopoietin-like protein 8 in early pregnancy improves the prediction of gestational diabetes
Huang, Y., Chen, X., Chen, X. N., Feng, Y. Y., Guo, H., Li, S., Ting, D., Jiang, R., Zhang, X., Fang, C., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4505-y · Cited by 34
Liu, Z., Zhao, J., Gao, L., & Wang, A. Y. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2276-9 · Cited by 32
The post-HAPO situation with gestational diabetes: the bright and dark sides
Lapolla, A., & Metzger, B. E. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1146-7 · Cited by 30
Long non-coding RNAs in placental development and disease
Basak, T., & Ain, R. (2019) · Non-coding RNA Investigation · doi:10.21037/ncri.2019.03.01 · Cited by 34
He, F., He, H., Liu, W., Lin, J., Chen, B., Lin, Y., Zhao, Y., Tao, W., & Xia, X. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12574 · Cited by 34
Fetal Growth Is Associated with Maternal Fasting Plasma Glucose at First Prenatal Visit
Liu, B., Chen, H., Xu, Y., An, C., Zhong, L., Wang, X., Zhang, Y., Chen, H., Zhang, J., & Wang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116352 · Cited by 30
Self-citationDiagnosis and Treatment of Hyperglycemia in Pregnancy
Mohan, S., & Egan, A. M. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.011 · Cited by 41
Wang, C., Wei, Y., Yang, Y., Su, R., Song, G., Kong, L., & Yang, H. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108736 · Cited by 32
Self-citationDiagnostic Strategies for Gestational Diabetes Mellitus: Review of Current Evidence
Kuo, C., & Li, H. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1271-x · Cited by 31
Performance of early risk assessment tools to predict the later development of gestational diabetes
Kotzaeridi, G., Blätter, J., Eppel, D., Rosicky, I., Mittlböck, M., Yerlikaya‐Schatten, G., Schatten, C., Husslein, P., Eppel, W., Huhn, E. A., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13630 · Cited by 27
Regnault, N., Lebreton, E., Tang, L., Fosse‐Edorh, S., Barry, Y., Olié, V., Billionnet, C., Weill, A., Vambergue, A., & Cosson, E. (2024) · Diabetologia · doi:10.1007/s00125-023-06066-4 · Cited by 31
“FPG level ≥5.0 mmol/l was found in 11.9% of pregnant women during the first trimester of pregnancy (on average at 9 GW) in Israel [30], while 11.4% had FPG >5.1 mmol/l at the first prenatal visit in China [31] and 7.2% in Italy [32].”
BackgroundInfluentialOral glucose tolerance test results in early pregnancy: A Finnish population-based cohort study
Jokelainen, M., Stach‐Lempinen, B., Rönö, K., Nenonen, A., Kautiainen, H., Teramo, K. A., & Klemetti, M. M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108077 · Cited by 28
Dainelli, L., Prieto Patron, A., Silva-Zolezzi, I., Sosa Rubi, S. G., Espino y Sosa, S., Reyes Muñoz, E., Lopez-Ridaura, R., & Detzel, P. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s160658 · Cited by 26
“31 Therefore, since in Mexico the overweight and obesity rate reaches 72.5%, 32 we would have expected the GDM incidence to be around 20%–25%, substantially higher than what has been reported in the national surveys and the teachers cohort study.”
InfluentialPrediction of gestational diabetes mellitus by multiple biomarkers at early gestation
Yang, M., Zhang, L., Wang, W., Huang, R., He, H., Zheng, T., Zhang, G.-H., Fang, F., Cheng, J., Li, F. R., et al. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06651-4 · Cited by 30
“ML model analyses showed that FPG and IGFBP-2 at early gestation were always selected in all ML models, and represented the minimal set of biomarkers in predicting GDM. FPG in the first-trimester is a known biomarker strongly predictive of GDM [14, 37, 38].”
MethodOptimal management of gestational diabetes
Egan, A. M., & Dunne, F. (2019) · British Medical Bulletin · doi:10.1093/bmb/ldz025 · Cited by 29
Chen, H., Wang, S., Li, H., Zhou, X., Zhou, L.-W., Chen, C., Mansell, T., Novakovic, B., Saffery, R., Baker, P. N., et al. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109708 · Cited by 28
Self-citationLiu, B., Geng, H., Yang, J., Zhang, Y., Deng, L., Chen, W., & Wang, Z. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-0846-7 · Cited by 28
“Discussion Fasting plasma glucose (FPG) at the first prenatal visit is related to the diagnosis of GDM [12], maternal pregravid BMI and neonatal birth weight [13].”
BackgroundSelf-citationRelationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study
Sweeting, A., Enticott, J., Immanuel, J., Hague, W. M., Teede, H. J., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M. P., Wong, V., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2214 · Cited by 30
Diagnosis, prevention and management of gestational diabetes mellitus
Wang, C., & Yang, H. (2016) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2016.11.004 · Cited by 31
“09 mmol/L should be considered a high-risk group for developing GDM and provided proper nutrition and exercise recommendation.(12)”
BackgroundSelf-citationShould the IADPSG criteria be applied when diagnosing early-onset gestational diabetes?
Hagiwara, Y., Kasai, J., Nakanishi, S., Saigusa, Y., Miyagi, E., & Aoki, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.048 · Cited by 24
Zhou, J., Wang, Y., Fan, Q., Liu, Y., Liu, H., Yan, J., Li, M., Dong, W., & Li, W. (2020) · The FASEB Journal · doi:10.1096/fj.201901674r · Cited by 26
Self-citationGestational diabetes in the first trimester: is early testing justified?
Sweeting, A., Ross, G. P., Hyett, J. A., & Wong, J. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30066-9 · Cited by 24
FIGO analysis of research priorities in hyperglycemia in pregnancy
McIntyre, D. H., Desoyé, G., Dunne, F., Siméoni, U., Visser, G. H. A., Kapur, A., & Hod, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.026 · Cited by 23
Self-citationAge at menarche and risk of gestational diabetes mellitus: a population-based study in Xiamen, China
Wang, L., Yan, B., Shi, X., Song, H., Su, W., Huang, B., Zhang, Y., Wang, S., Lv, F., Lin, M., et al. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2287-6 · Cited by 23
Self-citationInfluence of fetal sex on perinatal outcomes in women with gestational diabetes mellitus
Hu, J., Ge, Z., Xu, Q., Shen, S., Wang, Y., Zhu, D., & Bi, Y. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3245 · Cited by 23
“5%.(2) Unfortunately, the incidence of GDM continues to rise, and the epidemic of GDM is a great threat to maternal and neonatal health.”
BackgroundSelf-citationWei, Y.-M., Liu, X.-Y., Shou, C., Liu, X.-H., Meng, W.-Y., Wang, Z.-L., Wang, Y.-F., Wang, Y.-Q., Cai, Z.-Y., Shang, L.-X., et al. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000158 · Cited by 22
“Earlier diagnosis of GDM may trigger earlier blood glucose management and benefit the patients, but it is difficult to predict GDMbefore the24th gestationalweekbecause fast plasmaglucose (FPG) decreases as the gestational age increases.([7,8]) It is controversial that if FPG ≥5.”
BackgroundSelf-citationGao, S., & Wang, J. (2023) · Protein & Cell · doi:10.1093/procel/pwad029 · Cited by 22
“Based on a cohort consisting of 17,186 pregnant women, fasting plasma glucose ≥5.1 mmol/L at the first prenatal visit cannot be accepted as the criterion for diagnosis of GDM (Zhu et al., 2013).”
MethodResultInfluentialFeng, R., Liu, L., Zhang, Y.-Y., Yuan, Z., Gao, L., & Zuo, C. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.230718 · Cited by 25
Benhalima, K., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa831 · Cited by 23
Early pregnancy hyperglycaemia as a significant predictor of large for gestational age neonates
Jayasinghe, I. U., Koralegedara, I. S., & Agampodi, S. B. (2022) · Acta Diabetologica · doi:10.1007/s00592-021-01828-1 · Cited by 23
Vitacolonna, E., Succurro, E., Lapolla, A., Scavini, M., Bonomo, M. A., Cianni, G. D., Benedetto, A. D., Napoli, A., Tumminia, A., Festa, C., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01397-4 · Cited by 27
Developmental origins of type 2 diabetes: a perspective from China
Ma, R. C. W., Tsoi, K. Y., Tam, W. H., & Wong, C. K. C. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.48 · Cited by 24
Associations of Arginine with Gestational Diabetes Mellitus in a Follow-Up Study
Burzyńska-Pędziwiatr, I., Jankowski, A., Kowalski, K., Sendys, P., Zieleniak, A., Cypryk, K., Żurawska-Kliś, M., Woźniak, L. A., & Bukowiecka‐Matusiak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217811 · Cited by 22
“[11] undermined current opinions about the FPG index, exposing weakness in GDM diagnosis between 24 and 28 weeks of pregnancy, although they suggested considering the FPG value with the range given earlier as a high-risk marker.”
BackgroundPrognosis Associated with Sub-Types of Hyperglycaemia in Pregnancy
Cosson, E., Bentounes, S. A., Nachtergaele, C., Berkane, N., Pinto, S., Sal, M., Bihan, H., Tatulashvili, S., Portal, J.-J., Carbillon, L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173904 · Cited by 20
“1 mmo/L in early pregnancy (10% in Israel [23], China [12], and Italy [11]).”
BackgroundInfluentialZhou, Z., Chen, G., Fan, D., Rao, J., Li, P., Wu, S., Lin, D., Ma, H., Ye, S., Zhang, H., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00135 · Cited by 20
“Advance maternal age was identified as a risk factor for GDM (3, 10, 11).”
BackgroundSelf-citationPrediction of gestational diabetes mellitus by different obesity indices
Song, Z.-M., Cheng, Y., Li, T., Fan, Y., Zhang, Q., & Cheng, H. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04615-0 · Cited by 23
“Obesity is an independent high-risk factor for GDM[2, 3].”
BackgroundWang, S., Ma, J., & Yang, H. (2015) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2015.09.001 · Cited by 20
Self-citationLiu, P. J., Yao, A., Ma, L., Chen, X. Y., Yu, S., Liu, Y.-P., & Hou, Y. X. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02191-y · Cited by 23
Longitudinal changes in glucose during pregnancy in women with gestational diabetes risk factors
Dratver, M. B., Arenas, J., Thaweethai, T., Yu, C. L., James, K. E., Rosenberg, E. A., Callahan, M. J., CAYFORD, M., Tangren, J. S., Bernstein, S. N., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05622-0 · Cited by 20
Agarwal, M., Punnose, J., Sukhija, K., Sharma, A., & Choudhary, N. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.12.009 · Cited by 20
Kotzaeridi, G., Blätter, J., Eppel, D., Rosicky, I., Falcone, V., Adamczyk, G., Linder, T., Yerlikaya‐Schatten, G., Weißhaupt, K., Henrich, W., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204794 · Cited by 22
Bhattacharya, S., Nagendra, L., Dutta, D., Mondal, S., Bhat, S., Raj, J. M., Boro, H., Kamrul-Hasan, A. B. M., & Kalra, S. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103051 · Cited by 24
Gestational diabetes in China: challenges and coping strategies
Yan, J., & Yang, H. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70154-8 · Cited by 19
Self-citationQiu, J., Liu, Y., Zhu, W., & Zhang, C. (2020) · Medical Science Monitor · doi:10.12659/msm.925991 · Cited by 22
“80% of 1959 women) among the Chinese population [30].”
BackgroundSelf-citationYe, Y., Xiong, Y., Zhou, Q., Xiao, X., & Li, X. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab841 · Cited by 19
Self-citationBenhalima, K., Van Crombrugge, P., Devlieger, R., Verhaeghe, J., Verhaegen, A., De Catte, L., & Mathieu, C. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-66 · Cited by 18
“A recent evaluation of the FPG in the first prenatal visit to diagnose GDM in China showed that a FPG between 110-125 mg/dl was a much better predictor of the development of GDM and that for their population at least, a FPG ≥ 92mg/dl at first prenatal visit could not be supported as the criterion for diagnosis of GDM…”
BackgroundTiming of diagnosis of gestational diabetes and pregnancy outcomes: A retrospective cohort
Shub, A., Chee, T., Templeton, A., Boyce, D. J., McNamara, C., Houlihan, C. A., Churilov, L. P., & McCarthy, E. A. (2018) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12814 · Cited by 18
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Quaresima, P., Myers, S. H., Pintaudi, B., D’Anna, R., Morelli, M., & Unfer, V. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1501110 · Cited by 21
Zhang, C., Wei, Y., Sun, W., & Yang, H. (2019) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2019.92019 · Cited by 17
“5% of pregnant women suffer from GDM throughout China [1].”
BackgroundInfluentialSelf-citationKouhkan, A., Khamseh, M. E., Moini, A., Pirjani, R., Arabipoor, A., Zolfaghari, Z., Hosseini, R., & Baradaran, H. R. (2019) · PubMed Central · doi:10.22074/ijfs.2019.5505 · Cited by 22
Singh, C., Gupta, Y., Goyal, A., Kalaivani, M., Garg, V., Bharti, J., Singhal, S., Kachhawa, G., Kulshrestha, V., Kumari, R., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108409 · Cited by 18
Yin, B., Ding, L., Chen, Z., Chen, Y., Zhu, B., & Zhu, Y. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110673 · Cited by 17
Xiao, Y., Chen, W., Chen, R., Luo, A., Chen, D., Liang, Q., Liu, T., Chen, X., & Tan, W. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/2953502 · Cited by 18
Zawiejska, A., Wróblewska‐Seniuk, K., Gutaj, P., Mantaj, U., Gomulska, A., Kippen, J., & Wender-Ożegowska, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113553 · Cited by 18
“There is the paucity of data validating the use of the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria in early pregnancy for predicting gestational diabetes mellitus (GDM) in late-pregnancy or reducing adverse neonatal outcomes [6,14,15].”
MethodHuhn, E. A., Göbl, C. S., Fischer, T., Bernasconi, M. T., Kreft, M., Kunze, M., Vogt, D., Dölzlmüller, E., Jaksch‐Bogensperger, H., Heldstab, S. A., et al. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2022-000330 · Cited by 15
Variation in the classification of hyperglycaemia in pregnancy and its implication
Gupta, Y., Goyal, A., Kalra, S., & Tandon, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30018-8 · Cited by 16
Cosson, E., Vicaut, É., Berkane, N., Cianganu, T.-L., Baudry, C., Portal, J.-J., Boujenah, J., Valensi, P. E., & Carbillon, L. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.08.007 · Cited by 17
Chen, G., Sun, X., Wang, J., Dong, M., Ye, Y., Liu, X., Sun, J., Xiao, J., He, G., Hu, J., et al. (2021) · Environmental Research Letters · doi:10.1088/1748-9326/abe4f8 · Cited by 18
“5%, indicating the widespread prevalence of this disease [2, 3].”
BackgroundSelf-citationRecent Advances of LncRNA H19 in Diabetes
Bi, Y., Wang, Y., & Sun, X. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1769-5032 · Cited by 15
Self-citationHan, T., Chen, Q., Huang, J., Zhang, J., Li, A., Xu, W., Peng, Z., Li, Z., & Chen, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1202734 · Cited by 15
“Withdrawal criteria: (1) any clinical adverse event; (2) severe pain; (3) pregnant woman or family member who were unwilling to complete the study.”
BackgroundSu, R., Yan, J., & Yang, H. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4952801 · Cited by 17
“Gestational diabetes mellitus (GDM) is characterized by intrauterine hyperglycemia and has been reported to affect 17.5% of pregnant women in China [1].”
InfluentialSelf-citationNon-pharmacological management of gestational diabetes: The role of myo-inositol
Guardo, F. D., Currò, J. M., Valenti, G., Rossetti, P., Di Gregorio, L. M., Conway, F., Chiofalo, B., Garzon, S., Bruni, S., & Rizzo, G. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2019-0111 · Cited by 14
Wang, R., Yang, Q., Sun, T., Yan, Q., Li, X., Li, H., Tang, Y. Y., Yang, L., Sun, J., & Li, B. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s308287 · Cited by 15
“Moreover, GDM women with weekly exercise time 150 minutes had a 3.78–6.97-fold higher abnormal PG percentage than those with weekly exercise time ≥150 minutes, and GDM women with daily exercise time 30 minutes had a 1.56–3.53-fold higher abnormal PG percentage than those with daily exercise time ≥30 minutes, and GDM w…”
BackgroundMethodInfluentialSelf-citationGupta, Y., Singh, C., Goyal, A., Kalaivani, M., Bharti, J., Singhal, S., Kachhawa, G., Kulshrestha, V., Kumari, R., Mahey, R., et al. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13865 · Cited by 17
Maternal gestational weight gain and adverse pregnancy outcomes in non-diabetic women
Yin, B., Hu, L., Wu, K., Sun, Y., Meng, X., Zheng, W., & Zhu, B. (2023) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2023.2255010 · Cited by 13
“The prevalence of GDM has increased to 14.7– 20.9% in China, making it a significant public health concern (Zhu et al. 2013, Zhu et al. 2016).”
BackgroundInfluentialGestational Diabetes Mellitus: New Thinking on Diagnostic Criteria
Luo, J., Tong, L., Xu, A., He, Y., Huang, H., Qiu, D., Guo, X., Chen, H., Xu, L., Li, Y., et al. (2024) · Life · doi:10.3390/life14121665 · Cited by 20
Self-citationUniversal screening for hyperglycemia in early pregnancy and the risk of adverse pregnancy outcomes
Shen, L., Zhang, S., Wen, J., Liu, J., Lin, X., Zhu, C., Cai, S., Xie, L., Wang, Z., & Chen, H. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07253-4 · Cited by 15
“The ADA has defined FPG 6.1–6.9 mmol/L before 15 weeks of gestation to identify individuals at higher risk of adverse pregnancy and neo-natal outcomes since 2022 [40].”
InfluentialSelf-citationCurrent approach to early gestational diabetes mellitus: A clinical update
Goyal, A., & Gupta, Y. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103256 · Cited by 13
Wu, D., Zhang, J., Xiong, Y.-M., Wang, H., Lu, D., Guo, M., Zhang, J., Chen, L., Fan, J., Huang, H., et al. (2022) · Nutrients · doi:10.3390/nu14163295 · Cited by 14
“60 mM should be provided with nutrition and exercise advice in Chinese population [24,26,27].”
BackgroundGuo, F., Liu, Y., Ding, Z., Zhang, Y., Zhang, C., & Fan, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.666194 · Cited by 13
Yaqiong, L., Guohua, W., Fuyan, Y., Wei, L., Shi, D., & Yi, Z. (2020) · Medicine · doi:10.1097/md.0000000000021654 · Cited by 13
Li, S., Guo, H., Zhang, Y., Li, P., Zhou, P., Li-rong, S., Li, J., & Chen, L. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00657-0 · Cited by 13
Factors Influencing Adverse Pregnancy Outcomes in Gestational Diabetes Mellitus
Zhao, F., & Xiao, B. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/5177428 · Cited by 12
Zhang, Y., Chen, L., Zhang, L., Wu, Y., & Li, L. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05594-6 · Cited by 17
Duo, Y., Song, S., Qiao, X., Zhang, Y., Xu, J., Zhang, J., Peng, Z., Chen, Y., Nie, X., Sun, Q., et al. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01480-8 · Cited by 13
“Because a previous study revealed that an FBG level C 6.1 mmol/L in early pregnancy could predict the risk of GDM with a specificity of 100%, participants with an FBG level C 6.1 mmol/L at the first visit were excluded from our study [10].”
BackgroundResultInfluentialHong, S., Lee, S. M., Kwak, S. H., Kim, B. J., Koo, J. N., Oh, I. H., Oh, S., Kim, S. M., Shin, S., Kim, W. K., et al. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0126 · Cited by 15
“Elevated fasting glucose level in early pregnancy has been well known as a risk factor of GDM [33-35].”
Liu, P. J., Yao, A., Chen, X. Y., Liu, Y.-P., Ma, L., & Hou, Y. X. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02169-w · Cited by 13
Tai, Y., Lee, C., Kuo, C., Lin, M., Chen, K., Lin, S., & Li, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237224 · Cited by 14
“However, there is another study which evaluated the performance of FPG at FPV to predict GDM, and performance was not as good as our results [28].”
ResultCosma, V., Imbernon, J., Zagdoun, L., Boulot, P., Renard, É., Brunet, C., Marès, P., Rodier, M., Kabani, S., Dematteï, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89679-2 · Cited by 11
Zaccara, T. A., Paganoti, C. D. F., Mikami, F. C. F., Francisco, R. P. V., & da Costa, R. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192113719 · Cited by 13
“Moreover, the literature has questioned extrapolating the glycemic thresholds from the OGTT to an isolated FPG during early pregnancy [6,7,9,18,19].”
BackgroundInfluentialIdentification of severe gestational diabetes mellitus after new criteria used in China
Wei, Y., Yan, J., & Yang, H. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.151 · Cited by 13
Self-citationLi, P., Yin, Y., Lin, S., Cui, J., Zhou, S., Li, L., & Fan, J. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.02.007 · Cited by 13
Wang, R., Chen, J., Yao, F., Sun, T., Yan, Q., Li, H., Tang, Y. Y., Yang, Q., Li, B., Adams, R. D., et al. (2022) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2022.03.005 · Cited by 13
Tong, J.-N., Chen, Y.-X., Guan, X.-N., Liu, K., Yin, A.-Q., Zhang, H.-F., Wu, L.-L., & Niu, J.-M. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04874-x · Cited by 11
“However, it is estimated that in some countries with limited health care resources, the lack of universal screening may miss up to 43% of GDM patients [1].”
BackgroundSelf-citationWu, P., Wang, Y., Ye, Y., Yang, X., Lu, Q., Liu, Y., Zeng, H., Song, X., Yan, S., Wen, Y. R., et al. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3496 · Cited by 12
“5%, but wide variations across regions also existed.(2,3) GDM is associated with adverse pregnancy outcomes, neonatal complications, as well as with a long‐term risk of glucose metabolism disorder and cardiovascular disease in women and their offspring,(1,4,5) so understanding the pathophysiology and identifying early…”
BackgroundSelf-citationJiang, Y., Jiang, F., Li, M., Wu, Q., Xu, C., Zhang, R., Song, M., Wang, Y., Wang, Y., Chen, Y., et al. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04374-8 · Cited by 10
Self-citationZhang, S., Wang, J., Xu, F., Yang, J., Qin, Y., Leng, J., Li, N., Guo, J., Li, X., Gao, Z., et al. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00203-5 · Cited by 11
Self-citationCosson, E., Vicaut, É., Sandre-Banon, D., Gary, F., Pharisien, I., Portal, J.-J., Baudry, C., Cussac-Pillegand, C., Valensi, P. E., & Carbillon, L. (2019) · Diabetic Medicine · doi:10.1111/dme.14141 · Cited by 10
Zhang, C., Wang, L., Sun, W., Chen, L., Zhang, C., Hong, L., Yu, J., Fan, J., Ruan, H., Zheng, T., et al. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04039-2 · Cited by 10
Huhn, E. A., Kotzaeridi, G., Fischer, T., Bernasconi, M. T., Richter, A. S., Kunze, M., Dölzlmüller, E., Jaksch‐Bogensperger, H., Weidinger, L., Eppel, D., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06517-0 · Cited by 10
“Interestingly, some previous studies suggested that fasting glucose tends to decrease with advanced gestational age, whereas post-load glucose values tend to increase, suggesting that different thresholds are necessary in early and late pregnancy [32, 35].”
InfluentialAdvances in gestational diabetes mellitus screening: Emerging trends and future directions
Kaymak, D., & Ozgu-Erdinc, A. S. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i10.111309 · Cited by 11
Chinese Guidelines for Medical Nutrition Therapy for Patients with Diabetes (2022 Edition).
(2024) · PubMed Central · doi:10.6133/apjcn.202406_33(2).0001 · Cited by 15
Agha-Jaffar, R., Oliver, N. S., Kostoula, M., Godsland, I. F., Yu, C.-S., Terry, J., Johnston, D. G., Gable, D. R., & Robinson, S. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1593959 · Cited by 9
Xu, T., Lai, X., He, K., Ma, L., & Fang, H. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045503 · Cited by 9
Changing the protocol for gestational diabetes mellitus screening
Ng, D., Beckmann, M. M., McIntyre, D. H., & Wilkinson, S. A. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12346 · Cited by 9
Metadata
- Authors
- Zhu, W.-W., Yang, H.-X., Wei, Y.-M., Yan, J., Wang, Z.-L., Li, X.-L., Wu, H.-R., Li, N., Zhang, M.-H., Liu, X.-H., Zhang, H., Wang, Y.-H., Niu, J.-M., Gan, Y.-J., Zhong, L.-R., Wang, Y.-F., & Kapur, A.
- Affiliations
- Peking University First Hospital, Beijing, China
- Peking University First Hospital (CN)
- First Affiliated Hospital of Sun Yat-sen University, Guangdong, China
- First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Shanxi, China
- Aviation General Hospital, Beijing, China
- Tongzhou Maternal and Child Health Hospital of Beijing, Beijing, China
- Maternal and Child Health Hospital of Taiyuan, Shanxi, China
- West China Second University Hospital, Sichuan, China
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangdong, China
- Guangdong Women and Children Hospital, Guangdong, China
- Boai Hospital of Zhongshan, Guangdong, China
- ShenZhen People’s Hospital (CN)
- Miyunxian Hospital, Beijing, China
- World Diabetes Foundation (DK)
- Corresponding author
- Yang, Hui-xia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-02-13
- Volume
- 36
- Issue
- 3
- Pages
- 586-590
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3579369
- OpenAlex
- W2023573372
- Semantic Scholar
- 042fceb2f5b600693a6ea2771f9a132cc07be895
- Cited by
- 338
- References
- 20
- Citations by year
- 2026: 9 · 2025: 25 · 2024: 28 · 2023: 21 · 2022: 30 · 2021: 42 · 2020: 40 · 2019: 39 · 2018: 28 · 2017: 26 · 2016: 15 · 2015: 19 · 2014: 11 · 2013: 5
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- World Diabetes Foundation
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, fasting blood glucose, first prenatal visit, GDM diagnosis, 75 g oral glucose tolerance test, gestational age, diagnostic thresholds, pregnant women, China
- MeSH terms
- Blood Glucose, China, Fasting, Female, Gestational Age, Humans, Pregnancy, Prenatal Care, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.